Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer.

Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer.
Surg Clin North Am. 2018 Aug;98(4):787-800
Authors: Menta A, Fouad TM, Lucci A, Le-Petross H, Stauder MC, Woodward WA, Ueno NT, Lim B
Abstract
Inflammatory breast cancer (IBC) is a rare form of breast cancer that accounts for only 2% to 4% of all breast cancer cases. Despite its low incidence, IBC contributes to 7% to 10% of breast cancer caused mortality. Despite ongoing international efforts to formulate better diagnosis, treatment, and research, the survival of patients with IBC has not been significantly improved, and there are no therapeutic agents that specifically target IBC to date. The authors present a comprehensive overview that aims to assess the present and new management strategies of IBC.
PMID: 30005774 [PubMed - in process]

Source: Clinical Breast Cancer - July 15, 2018 Category: Cancer & Oncology Authors: Menta A, Fouad TM, Lucci A, Le-Petross H, Stauder MC, Woodward WA, Ueno NT, Lim B Tags: Surg Clin North Am Source Type: research